Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Change in Acquisitions & Divestments (2023 - 2025)

Collegium Pharmaceutical has reported Change in Acquisitions & Divestments over the past 3 years, most recently at $19.8 million for Q4 2025.

  • Quarterly results put Change in Acquisitions & Divestments at $19.8 million for Q4 2025, up 24.2% from a year ago — trailing twelve months through Dec 2025 was $65.2 million (down 29.62% YoY), and the annual figure for FY2025 was $65.2 million, down 29.62%.
  • Change in Acquisitions & Divestments for Q4 2025 was $19.8 million at Collegium Pharmaceutical, up from $14.6 million in the prior quarter.
  • Over the last five years, Change in Acquisitions & Divestments for COLL hit a ceiling of $29.4 million in Q3 2024 and a floor of $13.8 million in Q2 2025.
  • Median Change in Acquisitions & Divestments over the past 3 years was $17.0 million (2025), compared with a mean of $19.3 million.
  • Peak annual rise in Change in Acquisitions & Divestments hit 24.2% in 2025, while the deepest fall reached 50.49% in 2025.
  • Collegium Pharmaceutical's Change in Acquisitions & Divestments stood at $16.0 million in 2023, then dropped by 0.15% to $16.0 million in 2024, then rose by 24.2% to $19.8 million in 2025.
  • The last three reported values for Change in Acquisitions & Divestments were $19.8 million (Q4 2025), $14.6 million (Q3 2025), and $13.8 million (Q2 2025) per Business Quant data.